SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-245528
Filing Date
2021-08-13
Accepted
2021-08-13 09:11:35
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d73452ds3.htm S-3 538886
2 EX-1.2 d73452dex12.htm EX-1.2 253937
3 EX-4.6 d73452dex46.htm EX-4.6 346878
4 EX-4.7 d73452dex47.htm EX-4.7 338506
5 EX-5.1 d73452dex51.htm EX-5.1 37524
6 EX-23.1 d73452dex231.htm EX-23.1 2802
7 EX-23.2 d73452dex232.htm EX-23.2 1501
8 GRAPHIC g73452sp148.jpg GRAPHIC 3061
9 GRAPHIC g73452sp149.jpg GRAPHIC 1730
  Complete submission text file 0001193125-21-245528.txt   1528051
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-258783 | Film No.: 211169948
SIC: 2834 Pharmaceutical Preparations